about
Blood cells: an historical account of the roles of purinergic signallingPlatelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapiesProjected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project).Virulence and thrombocyte affectation of two Aspergillus terreus isolates differing in amphotericin B susceptibility.A novel role of Eruca sativa Mill. (rocket) extract: antiplatelet (NF-κB inhibition) and antithrombotic activities.Translating from the rivers of Babylon to the coronary bloodstreamP2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activity.Synthesis of N-arylmethyl Substituted Indole Derivatives as New Antiplatelet Aggregation Agents.Parietal and intravascular innate mechanisms of vascular inflammation.Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: An in vitro study.Ticagrelor: An emerging oral antiplatelet agent.Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.The influence of Rubus idaeus and Rubus caesius leaf extracts on platelet aggregation in whole blood. Cross-talk of platelets and neutrophils.Panax quinquefolius saponins combined with dual antiplatelet drug therapy alleviate gastric mucosal injury and thrombogenesis through the COX/PG pathway in a rat model of acute myocardial infarction.The basis examination of leukocyte-platelet aggregates with CD45 gating as a novel platelet activation marker
P2860
Q26799623-EB25B4D1-FFE7-4B02-871B-C28B722828BAQ28068448-7449AFDA-ACB8-4901-9C11-0416D160B6CFQ30827217-1A3BCCEA-5225-482F-8FB6-CECC3972519DQ33408090-B7928A61-19CB-47ED-96E2-DE89025E184FQ34775072-C7A29D05-860E-42DD-B066-04707E71FFD0Q36357988-AF2A326C-50D9-4B07-ABAC-56C5092F0BFEQ36974211-96FBA315-1552-4E8A-B5F7-6493F8665AA0Q37687166-3D6B8204-79F3-400F-BDC7-A75CA774312EQ38427670-D704A273-F7B1-48BA-84FD-20AF9A72B8C5Q38776693-73EA4149-88C8-4E7B-98BE-4DF7A5364B99Q40359329-9B832211-4EA0-4E97-B4AF-545E16652705Q41561509-5576C86C-00C4-480F-816D-176F5B25014AQ46601684-651199A5-160E-4320-B3A2-06FADE909F29Q55014341-6D58F584-90B6-40A9-A78B-2685E71787DDQ57147305-6202F188-46D1-43EC-8D3C-E2738D195548
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Advances in antiplatelet therapy.
@ast
Advances in antiplatelet therapy.
@en
Advances in antiplatelet therapy.
@nl
type
label
Advances in antiplatelet therapy.
@ast
Advances in antiplatelet therapy.
@en
Advances in antiplatelet therapy.
@nl
prefLabel
Advances in antiplatelet therapy.
@ast
Advances in antiplatelet therapy.
@en
Advances in antiplatelet therapy.
@nl
P1476
Advances in antiplatelet therapy.
@en
P2093
Alan D Michelson
P356
10.1182/ASHEDUCATION-2011.1.62
P577
2011-01-01T00:00:00Z